IBEX (IBEX) Proxy Filing summary

Board of directors and corporate governance

• A formal Nominating Committee was established on November 20, 2025, to oversee director nominations and related governance matters.

• The Committee consists of five independent directors, all meeting Nasdaq and SEC independence standards.

• The Committee ratified prior actions by independent board members and renominated the current slate of director candidates for the December 5, 2025, annual meeting.

• Formation of the Committee addresses concerns raised by Institutional Shareholder Services and Glass Lewis regarding the nominating process.

• The Board and Committee unanimously recommend voting "FOR" all director nominees.

Voting matters and shareholder proposals

• Shareholders are urged to vote "FOR" each of the Board nominees at the annual meeting scheduled for December 5, 2025.

• Shareholders who have already submitted proxies may submit a new one to change their vote, with the latest submission superseding prior proxies.

Related party transactions

• Information about directors' and executive officers' security holdings and any changes are disclosed in the Proxy Statement and Form 4 filings.

• Additional details on direct and indirect interests of participants in the proxy solicitation are available in the Proxy Statement.